JB
GPCR icon

Julian Baker’s Structure Therapeutics GPCR Stock Holding History

Julian Baker’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.9M Hold
1,432,529
– – 0.39% 31
2026
Q1 		$69M Hold
1,432,529
– – 0.4% 33
2025
Q4 		$99.6M Sell
1,432,529
-123,580
-8% -$5.05M 0.58% 26
2025
Q3 		$43.6M Sell
1,556,109
-952,658
-38% -$19M 0.31% 32
2025
Q2 		$52M Buy
2,508,767
+2,147,202
+594% +$47.2M 0.5% 25
2025
Q1 		$6.26M Hold
361,565
– – 0.07% 56
2024
Q4 		$9.81M Buy
361,565
+276,065
+323% +$9.79M 0.1% 53
2024
Q3 		$3.75M Buy
+85,500
New +$3.31M 0.04% 73

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Julian Baker's GPCR Position: Q2 2026 in Review

Julian Baker held its Structure Therapeutics (GPCR) position steady in Q2 2026 at 1,432,529 shares worth $76.9M. The position accounts for 0.39% of the portfolio, ranked #31.

Julian Baker first reported a position in GPCR in Q3 2024 and has held it in 8 quarters since. The position peaked at $99.6M in Q4 2025. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Julian Baker held 1,432,529 shares of Structure Therapeutics worth $76.9M as of Q2 2026.
  • Julian Baker left its Structure Therapeutics share count unchanged in Q2 2026.
  • Structure Therapeutics made up 0.39% of Julian Baker's portfolio in Q2 2026, its #31 holding.
  • Julian Baker first reported a position in Structure Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Julian Baker's Structure Therapeutics position peaked at $99.6M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Baker Bros. Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.